In case of anastrozole-related hallucinations, can switching to letrozole be a treatment option? A case report and literature review.
Arthralgia, myalgia, paresthesia, reduced bone mineral density, vasomotor side effects including hot flashes and night sweats, genitourinary symptoms including decreased libido, vaginal dryness and dyspareunia are common side effects of aromatase inhibitors. Unlike the common side effects, the information on neurological side effects like hallucination of aromatase inhibitor was limited in literature cases. Herein, we reported a case of hallucination related to anastrozole in a patient with metastatic breast cancer. A 62-year-old female patient with breast cancer developed repetitive hallucinations on the following days of anastrozole initiation. There was no other significant finding in the differential diagnosis of hallucination. Neurological symptoms disappeared after termination of anastrozole. The patient had no neuropsychiatric complaints during letrozole treatment. We aimed to emphasize that neurological side effect like hallucination may rarely occur during the treatment of anastrozole and in case of aromatase inhibitor-related hallucinations, switching to another aromatase inhibitor (letrozole) can be a treatment option.